Cataract & Refractive

Latest News


CME Content


Ophthalmic surgeons have been implanting multifocal lenses for several years, not only in cataract surgery, but also to offset the accommodation lost as a consequence of age. With the newest generation of lenses, more than 80% of refractive and cataract patients can now enjoy life without glasses.

The first generation Crystalens accommodating intraocular lens (IOL) (eyeonics) was approved by the FDA in November 2003 and has since undergone two revisions. The first involved modification of the lens optic to a "square" rather than smooth edge in order to reduce the incidence of asymmetric capsular fibrosis, which could cause capsular contraction and IOL tilt

It has been discovered that the equatorial diameter of a lens directly influences accommodation and thus presents a sound target for presbyopia treatment interventions

Presbyopia Correcting IOLs (PCIOLs) are perhaps the most significant technological advancement in recent ophthalmic history. These lenses not only provide patients with the option of seeing near, intermediate, and distant objects without dependence on glasses for most of their daily activities - they could also become the single most important cornerstone for building a successful ophthalmic practice, both now and in the foreseeable future.

Cataract & Refractive 2007

A look back at what happened in the fields of cataract & refractive surgery in 2007 and what we can look forward to in 2008.

LASIK 5 years on…

LASIK is a safe and effective procedure in the correction of myopia five years after surgery, according to a study in the September issue of Ophthalmology.

Topical nonsteroidal anti-inflammatory drugs (NSAIDs) are often used off-label for multiple purposes in cataract surgery, but such treatment is often being administered with limited supporting evidence and carries a high cost along with potential risks.